RESULTS:: Thirty-day mortality (MT) was 5.9% and morbidity (MB) was 30.0%. Patient age, especially age greater than 80 years, (MT: (OR 2.41 95% CI: 1.17-4.99) MB: (OR 1.43 95% CI: 1.05-1.94)) and male sex (MT: (OR 2.28 95% CI: 1.61-3.22) MB: (OR 1.26 95% CI: 1.03-1.54)) were associated with both increased mortality and morbidity. An increased ASA Class had the highest negative impact on total complication incidence in the scoring models. Additionally, complete functional dependence, active malignancy, patient race, cardio-pulmonary disease, laboratory derangements, prolonged operating time, and open versus percutaneous surgery independently influenced outcomes. Risk scores, based on weighted models which included the aforementioned variables, predicted mortality (p < 0.001, C-index 0.702) and morbidity (p < 0.001, C-index 0.670) after hip fracture surgery.
CONCLUSIONS:: In this study, we have developed an internally validated method for risk stratifying patients undergoing hip fracture surgery, and this model is predictive of both 30-day morbidity and mortality. Our model could be useful for identifying high-risk individuals, for obtaining informed consent, and for risk adjusted comparisons of outcomes between institutions.
LEVEL OF EVIDENCE:: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

PMID: 23872716 [PubMed - as supplied by publisher]

Read more... http://www.ncbi.nlm.nih.gov/pubmed/23872716?dopt=Abstract